ETON PHARMACEUTICALS INC (ETON)

US29772L1089 - Common Stock

3.75  +0.04 (+1.08%)

After market: 3.76 +0.01 (+0.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024
Revenue
YoY % growth
21.83M
54,475.00%		21.25M
-2.66%		31.642M
48.90%		42.228M
33.46%
EBITDA
YoY % growth
-1.04M
96.07%		-6.98M
-571.15%		-291K
95.83%		N/A
EBIT
YoY % growth
-1.5M
94.47%		-8.75M
-483.33%		-1.192M
86.38%		2.868M
340.60%
Operating Margin
-6.87%-41.18%-3.77%6.79%
EPS
YoY % growth
-0.11
91.91%		-0.35
-218.18%		-0.06
82.86%		0.27
542.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.02
79.60%
Revenue
Q2Q % growth		8.466M
59.74%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.09
-325.00%		-0.04-0.05-120.59%
Q3 2023
Q2Q % growth		 -0.02
83.33%		-0.100.0880.39%
Q2 2023
Q2Q % growth		 0.15
350.00%		-0.090.24263.40%
Q1 2023
Q2Q % growth		 -0.10
52.38%		-0.140.0429.97%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 7.313M
-13.96%		7.854M-541K-6.89%
Q3 2023
Q2Q % growth		 7.03M
118.32%		6.384M646K10.12%
Q2 2023
Q2Q % growth		 12M
63.04%		6.639M5.361M80.75%
Q1 2023
Q2Q % growth		 5.3M
143.12%		4.647M653K14.05%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%